Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10220275 | 0.84 | LMNA (0.39) | LMNA | |
| SCHEMBL18701512 | 0.77 | — | — | |
| SCHEMBL32675830 | 0.74 | LMNA (0.32) | LMNA | |
| SCHEMBL18701497 | 0.74 | — | — | |
| SCHEMBL275638 | 0.74 | — | — | |
| SCHEMBL14967319 | 0.72 | LMNA (0.37) | LMNA | |
| SCHEMBL22055454 | 0.72 | LMNA (0.37) | LMNA | |
| SCHEMBL29464296 | 0.72 | LMNA (0.37) | LMNA | |
| SCHEMBL2396549 | 0.68 | LMNA (0.44) | LMNA | |
| SCHEMBL14438127 | 0.68 | LMNA (0.34) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260052896-A1 | METAL CARBENE COMPLEX AND ITS USE | UNIV CITY HONG KONG (HK) | 2026-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260052896-A1 | METAL CARBENE COMPLEX AND ITS USE | CYBA, OPRD1, OXER1 | LMNA 3822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.